UN-KPC-961 cells were obtained from S. K. Batra at Eppley Institute for Research in Cancer (Omaha, Nebraska). COLO 205 (CCL-222), HCT15 (CCL-225), HT29 (HTB-38), SW480 (CCL-228), HCT116 (CCL-247), HCT8 (CCL-244), NCI-H508 (CCL-253), HepG2 (HB-8065), Hs746T (HTB-135), CT26 (CRL-2638), LS-174T (CL-88), PANC1 (CRL-1469), and NCI-N87 (CRL-5822) cell lines were purchased from the American Type Culture Collection (ATCC) (Baltimore, MD) and maintained in standard conditions following the providers’ instructions. MC38 cells were purchased from Kerafast (Boston, MA). Lvm3b was generated by in vivo selection from the parental cell line LS-174T (ATCC, Baltimore, MD) (15 (link)). UN-KPC-961 cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM) (Gibco, Langley, OK, 11960-044), 7.5% sodium bicarbonate (Gibco, Langley, OK, 25080-094), 1% penicillin-streptomycin (Lonza, 17-745E), 10% fetal bovine serum (FBS) (Sigma-Aldrich, St. Louis, MO, F4135), 200 mM l-glutamine (Gibco, Langley, OK, 25030081), 1 mM Hepes (Gibco, Langley, OK, 15630080), and gentamicin (50 mg/ml) (Gibco, Langley, OK, 15750078). MC38 cells were cultured in DMEM, 10% FBS, and 1 mM Hepes.